China
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 295.23
|
Dec. 31, 2023 | USD 23.54 | -4.27% |
|
China |
|
2 |
USD 150.90
|
Dec. 31, 2023 | USD 2.66 | -5.34% |
|
China |
|
3 |
USD 119.75
|
Dec. 31, 2023 | USD 1.13 | -2.59% |
|
China |
|
4 |
USD 107.02
|
March 31, 2024 | USD 1.94 | -1.52% |
|
China |
|
5 |
USD 98.05
|
Dec. 31, 2023 | USD 5.52 | 2.60% |
|
China |
|
6 |
USD 93.90
|
Dec. 31, 2023 | USD 1.33 | 0.76% |
|
China |
|
7 |
USD 89.14
|
Dec. 31, 2023 | USD 3.60 | 2.56% |
|
China |
|
8 |
USD 74.74
|
Dec. 31, 2023 | USD 3.01 | -4.14% |
|
China |
|
9 |
USD 62.56
|
Dec. 31, 2023 | USD 2.68 | -0.74% |
|
China |
|
10 |
USD 51.20
|
Dec. 31, 2023 | USD 15.08 | 6.95% |
|
China |
|
11 |
USD 50.88
|
March 31, 2024 | USD 10.26 | 2.34% |
|
China |
|
12 |
USD 48.59
|
Dec. 31, 2023 | USD 17.45 | 5.32% |
|
China |
|
13 |
USD 37.83
|
Dec. 31, 2023 | USD 0.83 | 3.39% |
|
China |
|
14 |
USD 35.21
|
Dec. 31, 2023 | USD 1.33 | 2.20% |
|
China |
|
15 |
USD 30.89
|
Dec. 31, 2023 | USD 19.55 | 5.33% |
|
China |
|
16 |
USD 29.82
|
Dec. 31, 2023 | USD 26.15 | -3.72% |
|
China |
|
17 |
USD 29.14
|
Dec. 31, 2023 | USD 32.99 | 3.11% |
|
China |
|
18 |
USD 28.24
|
Dec. 31, 2023 | USD 12.98 | 2.37% |
|
China |
|
19 |
USD 27.05
|
Dec. 31, 2023 | USD 0.92 | 2.25% |
|
China |
|
20 |
USD 26.96
|
Dec. 31, 2023 | USD 2.59 | 1.33% |
|
China |
|
21 |
USD 26.15
|
Dec. 31, 2023 | USD 44.01 | 4.04% |
|
China |
|
22 |
USD 25.88
|
Dec. 31, 2023 | USD 0.85 | 5.05% |
|
China |
|
23 |
USD 25.27
|
Dec. 31, 2023 | USD 4.40 | 5.22% |
|
China |
|
24 |
USD 25.08
|
May 31, 2024 | USD 5.94 | -3.67% |
|
China |
|
25 |
USD 24.34
|
Dec. 31, 2023 | USD 10.85 | 3.53% |
|
China |
|
26 |
USD 23.91
|
Dec. 31, 2023 | USD 98.13 | 2.24% |
|
China |
|
27 |
USD 23.84
|
Dec. 31, 2023 | USD 0.80 | 3.52% |
|
China |
|
28 |
USD 23.13
|
Dec. 31, 2023 | USD 2.89 | -5.25% |
|
China |
|
29 |
USD 22.04
|
Dec. 31, 2023 | USD 5.51 | -2.82% |
|
China |
|
30 |
USD 22.04
|
Dec. 31, 2023 | USD 0.86 | 2.11% |
|
China |
|
31 |
USD 21.23
|
Dec. 31, 2023 | USD 1.64 | 0.13% |
|
China |
|
32 |
USD 20.86
|
Dec. 31, 2023 | USD 0.93 | 2.96% |
|
China |
|
33 |
USD 20.68
|
Dec. 31, 2023 | USD 1.93 | 0.24% |
|
China |
|
34 |
USD 20.12
|
Dec. 31, 2023 | USD 0.67 | 2.96% |
|
China |
|
35 |
USD 19.23
|
Dec. 31, 2023 | USD 6.92 | 1.92% |
|
China |
|
36 |
USD 19.09
|
Dec. 31, 2023 | USD 3.94 | -0.25% |
|
China |
|
37 |
USD 19.08
|
Dec. 31, 2023 | USD 3.66 | 2.21% |
|
China |
|
38 |
USD 17.64
|
Dec. 31, 2023 | USD 2.36 | -1.67% |
|
China |
|
39 |
USD 17.61
|
Dec. 31, 2023 | USD 12.09 | 1.60% |
|
China |
|
40 |
USD 17.33
|
Dec. 31, 2023 | USD 4.77 | 5.76% |
|
China |
|
41 |
USD 17.26
|
Dec. 31, 2023 | USD 18.98 | 1.99% |
|
China |
|
42 |
USD 17.08
|
June 30, 2024 | USD 1.53 | NA |
|
China |
|
43 |
USD 16.56
|
Dec. 31, 2023 | USD 200.79 | 1.98% |
|
China |
|
44 |
USD 16.54
|
Dec. 31, 2023 | USD 11.32 | 3.32% |
|
China |
|
45 |
USD 15.96
|
Dec. 31, 2023 | USD 0.65 | 2.60% |
|
China |
|
46 |
USD 15.32
|
Dec. 31, 2023 | USD 2.50 | 1.61% |
|
China |
|
47 |
USD 15.09
|
Dec. 31, 2023 | USD 34.94 | 3.77% |
|
China |
|
48 |
USD 14.53
|
Dec. 31, 2023 | USD 1.68 | 2.25% |
|
China |
|
49 |
USD 14.38
|
Dec. 31, 2023 | USD 7.40 | 4.23% |
|
China |
|
50 |
USD 14.21
|
Dec. 31, 2023 | USD 6.85 | 0.26% |
|
China |
The company in China with the highest Revenue Per Share is JinkoSolar Holding Co., Ltd. (NYSE: JKS) at USD 295.23.
The company in China with the lowest Revenue Per Share is Shanghai Bio-heart Biological Technology Co., Ltd. (HKSE: 2185.HK) at USD 0.00.
The top 10 companies in China by Revenue Per Share are JinkoSolar Holding Co., Ltd., Xinyuan Real Estate Co., Ltd., Ucommune International Ltd, China Jo-Jo Drugstores, Inc., Nisun International Enterprise Development Group Co., Ltd, Quhuo Limited, ZKH Group Limited, Jowell Global Ltd., BEST Inc. and The9 Limited.
The bottom 10 companies in China by Revenue Per Share are Shanghai Bio-heart Biological Technology Co., Ltd., Genor Biopharma Holdings Limited, Connect Biopharma Holdings Limited, HighTide Therapeutics Inc, GD Culture Group Limited, ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Tieling Newcity Investment Holding (Group) Limited, Abbisko Cayman Limited, Zhaoke Ophthalmology Limited and Kingland Technology Co.,Ltd..